Nasus Pharma Ltd. (NSRX) Income Statement

27 Followers

Nasus Pharma Ltd. Income Statement

Last quarter (Q2 2026), Nasus Pharma Ltd.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Nasus Pharma Ltd.'s net income was $-5.94M. See Nasus Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 4.90M
Depreciation and Amortization	$ 0.00
EBITDA	$ -4.90M
Operating Income	$ -4.90M
Other Income/Expenses	$ -901.00K
Pretax Income	$ -5.80M
Net Income	$ -5.86M
Per Share Metrics
Basic EPS	$ -0.72
Diluted EPS	$ -0.72
Weighted Average Shares Outstanding	8.01M
Weighted Average Shares Outstanding (Diluted)	8.01M

Currency in USD

Nasus Pharma Ltd. (NSRX) Income Statement

Nasus Pharma Ltd. Income Statement

Nasus Pharma Ltd. Earnings and Revenue History